🔬 On November 14th

I had an exciting discussion on the use of specialized "AI tools in early drug discovery" with David Egan, CEO of Core Life Analytics, and Philipp Kainz, CEO of KML Vision.

We discussed the use of the latest developments in advanced machine learning and deep learning research that have the potential to significantly enhance research efforts in early drug discovery. In addition to all the opportunities and benefits that these modern AI tools bring, we will also and most importantly address the inflated expectations, exaggerated fears, and drawbacks that this modern approach also brings.

🧠 Learn how to get the most out of your data with the safe use of AI tools.

📺 This was a live streaming event. The recording of the talk is now also available as this podcast.

Enjoy the show, Stefan

Hosted on Acast. See acast.com/privacy for more information.